We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WTW icon
751
Willis Towers Watson
WTW
$32B
$73K ﹤0.01%
321
+51
+19% +$11.1K
KRTX
752
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$73K ﹤0.01%
610
-10
-2% -$1.13K
ANSS
753
DELISTED
Ansys
ANSS
$72K ﹤0.01%
213
+34
+19% +$12.1K
DFS
754
DELISTED
Discover Financial Services
DFS
$72K ﹤0.01%
766
+120
+19% +$11.3K
FAST icon
755
Fastenal
FAST
$59.5B
$72K ﹤0.01%
2,900
+464
+19% +$11.1K
ARVN icon
756
Arvinas
ARVN
$572M
$71K ﹤0.01%
1,075
+140
+15% +$10.7K
KYNB
757
Kyntra Bio
KYNB
$29.4M
$71K ﹤0.01%
82
-1
-1% -$1.06K
VRSK icon
758
Verisk Analytics
VRSK
$25B
$71K ﹤0.01%
406
+64
+19% +$11.7K
VINC
759
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$71K ﹤0.01%
+186
New +$75K
AMP icon
760
Ameriprise Financial
AMP
$48.8B
$70K ﹤0.01%
302
+48
+19% +$10.4K
RLAY icon
761
Relay Therapeutics
RLAY
$4.33B
$70K ﹤0.01%
2,035
-30
-1% -$1.3K
UK icon
762
Ucommune International Ltd Class A Ordinary Shares
UK
$1.44M
$70K ﹤0.01%
10
-5
-33% -$47.4K
AWK icon
763
American Water Works
AWK
$26.9B
$69K ﹤0.01%
464
+80
+21% +$12.1K
RETA
764
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$69K ﹤0.01%
700
+35
+5% +$4.08K
ALLY icon
765
Ally Financial
ALLY
$13.3B
$68K ﹤0.01%
1,515
+532
+54% +$22.3K
PCRX icon
766
Pacira BioSciences
PCRX
$997M
$68K ﹤0.01%
980
-15
-2% -$1.07K
ALKS icon
767
Alkermes
ALKS
$8.25B
$67K ﹤0.01%
3,600
-80
-2% -$1.64K
MTD icon
768
Mettler-Toledo International
MTD
$28.6B
$67K ﹤0.01%
58
+9
+18% +$10.4K
TTD icon
769
Trade Desk
TTD
$6.49B
$67K ﹤0.01%
1,040
-85,090
-99% -$6.58M
ALXO icon
770
ALX Oncology
ALXO
$290M
$66K ﹤0.01%
900
+50
+6% +$3.93K
BBY icon
771
Best Buy
BBY
$17.3B
$66K ﹤0.01%
578
+88
+18% +$9.85K
FITB
772
Fifth Third Bancorp
FITB
$51.8B
$66K ﹤0.01%
1,786
+280
+19% +$9.49K
GCMG icon
773
GCM Grosvenor
GCMG
$820M
$66K ﹤0.01%
5,570
-10,249
-65% -$133K
KKR icon
774
KKR & Co
KKR
$92.3B
$66K ﹤0.01%
1,359
+233
+21% +$10.4K
OKTA icon
775
Okta
OKTA
$25.8B
$66K ﹤0.01%
300
+48
+19% +$12.1K

Similar funds

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.